base metals investing Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
base metals investing Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
base metals investing Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
base metals investing Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
base metals investing Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
base metals investing Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
base metals investing Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
base metals investing OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
SAGA Metals Mobilizes Camp Construction Ahead of Drilling at Wolverine Heavy Rare Earth Element Project in Labrador
